Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Completed 2Active not recruiting 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Sarcoma 1

Conditions

Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Pioglitazone × 1 year × Clear all
NCT07604779 2026-05-22

Enhancing PCOS Management for Better Outcomes of Intracytoplasmic Sperm Injection

Beni-Suef University

Phase NA Active not recruiting
150 enrolled

Polycystic Ovary Syndrome

NCT02133625 2026-03-30

A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors

Dana-Farber Cancer Institute

Phase 1 Completed
14 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04794127 2026-02-18

TRABEPIO

Mario Negri Institute for Pharmacological Research

Phase 2 Completed
10 enrolled
Sarcoma

Liposarcoma, Liposarcoma, Myxoid

NCT05919147 2025-07-04

TRACE-1

Pennington Biomedical Research Center

Phase 2 Active not recruiting
24 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡